Organization
Canadian Life and Health Insurance Association Inc.
- Meetings this Parliament
- 78
- With MPs
- 12
- Since Nov 2021
- 244
- Active registrations
- 1
Most recent reported meeting: Sep 23, 2026.
Lobbying by Canadian Life and Health Insurance Association Inc.: its registrations, its lobbyists, the bills it has named and every meeting it has reported with federal office holders since November 2021.
← LobbyingBills they've lobbied on
Named in their own descriptions of meetings or of their registration. Their words are quoted below each bill.
-
Bill S-5 21 mentions · latest Oct 5, 2026 In registration
“Discussions related to Bill S-5 Connected Care for Canadians Act.”
-
Bill C-242 44-1 (previous Parliament) 19 mentions · latest Apr 22, 2025 In registration
“…insurance for temporary residents in Canada as allowed under the Bill formerly known as C-242. The legislation amends the Immigration and Refugee Protection Act to allow a parent or grandparent who applies for a temporary resident visa as a visitor to purchase…”
-
Bill C-22 44-1 (previous Parliament) 18 mentions · latest Apr 22, 2025 In registration
“…of the regulations and how benefits are defined related to the Bill formerly known as C-22, the Canada Disability Benefit Act.”
Who they meet
Since the current Parliament opened.
MPs
- Adam Chambers Conservative 4
- Peter Fonseca Liberal 2
- William Stevenson Conservative 1
- Chi Nguyen Liberal 1
- Tim Hodgson Liberal 1
- Maggie Chi Liberal 1
- Marjorie Michel Liberal 1
- Raquel Dancho Conservative 1
- Mel Arnold Conservative 1
- James Maloney Liberal 1
- Wayne Long Liberal 1
- Ted Falk Conservative 1
Institutions
- Finance Canada (FIN)18
- Health Canada (HC)13
- House of Commons10
- Senate of Canada8
- Privy Council Office (PCO)4
- Employment and Social Development Canada (ESDC)4
- Prime Minister's Office (PMO)3
- Office of the Superintendent of Financial Institutions Canada (OSFI)3
Registrations in effect
In-house (organization) In effect since Oct 5, 2026
Filed by Stephen Frank, President and Chief Executive Officer
Lobbyists
-
David McArthur · Vice-President, Government Relations and Public Affairs
Former designated public office holder
Formerly Chief of Staff, Minister's Office, Natural Resources Canada (2014–2015)
Formerly Chief of Staff, Minister's Office, Heritage Canada (2013–2014)
Formerly Chief of Staff, Minister's Office, Indigenous and Northern Affairs Canada (2010–2012)
Formerly Senior Special Assistant, Minister's Office, Indigenous and Northern Affairs Canada (2009–2010)
- Anastasiya Matrosova · Director, Tax and Reporting Policy
-
Andrea Mayer · Senior Analyst, Policy
Former public office holder
Formerly Junior Quantitative Analyst, Security, Canada Revenue Agency (2025–2025)
Formerly Junior Policy Analyst, Service, Innovation, and Integration Branch, Canada Revenue Agency (2023–2025)
Formerly Planning and Project Officer, Service, Innovation, and Integration Branch, Canada Revenue Agency (2023–2023)
Formerly Planning and Project Support Officer, Finance and Administration Branch, Canada Revenue Agency (2022–2023)
- Anna Laurence · Assistant Vice President, Government Relations
- Barbara Carnegie · Vice President Healthcare and Group Benefits
- Dave Whyte · Director, Pension Policy & Governance
-
Dominique Biron-Bordeleau · AVP, Public and Government Affairs
Former public office holder
Formerly Internship Program, Service, Innovation, and Integration Branch, House of Commons (2011–2012)
Formerly Human Resources Trainee, Human Recourse, Industry Canada (2007–2009)
- Erica Kelsey · Director, Government and Industry Affairs
-
Ethan Kohn · Senior Legal Counsel
Former public office holder
Formerly Economist, Financial Institution, Finance Canada (1987–1993)
- Giulia Ahmadi · Vice President and General Counsel
- Harpreet Roopra · Assistant Vice President, Reporting and Corporate Tax Policy
- James Wood · Senior Legal Counsel
- Joanne Bradley · Vice President, Anti-Fraud
- Jonathan Mitchell · Director, Healthcare
- Lyne Duhaime · President, Quebec Affairs and Senior Vice President, Market Conduct Policy and Regulation
-
Nathan Holman · Director, Government and Industry Affairs
Former public office holder
Formerly Economist, Competition and Strategic Initiatives, Financial Sector Policy Branch, Finance Canada (2023–2025)
Formerly Policy Advisor, Legislative Governance, Environment and Climate Change Canada (2022–2023)
Formerly Analyst, External and Trade Policy Branch, Innovation, Science and Economic Development Canada (2021–2022)
- Richelle Feddema · Director, Anti-Fraud Member Management
-
Sarah Hobbs · Vice-President, Policy
Former public office holder
Formerly Economist, Financial Sector Policy Branch, Finance Canada (2011–2014)
Formerly Economist, Federal-Provincial Relations Branch, Finance Canada (2009–2011)
- Stephanie Wong · Director, Policy
-
Stephen Frank · President and Chief Executive Officer
Former public office holder
Formerly Economist, Financial Sector Policy Branch, Department of Finance (1998–2000)
Formerly Research Associate: Task Force on the Future of the Canadian Financial Services Sector, Financial Sector Policy Branch, Department of Finance (1997–1997)
-
Susan Murray · VP, Government Relations and Public Affairs
Former public office holder
Formerly Executive Director, Financial Literacy Task Force, Financial Sector Policy, Department of Finance (2009–2011)
Formerly Director, Financial Literacy, N/A, Financial Consumer Agency of Canada (2007–2008)
Formerly Director, Consumer Education and Public Affairs, N/A, Financial Consumer Agency of Canada (2002–2007)
Institutions they may lobby: Agriculture and Agri-Food Canada (AAFC), Canada Employment Insurance Commission, Canada Revenue Agency (CRA), Canadian Heritage (PCH), Canadian Human Rights Tribunal (CHRT), Canadian Radio-television and Telecommunications Commission (CRTC), Canadian Transportation Agency (CTA), Employment and Social Development Canada (ESDC), Finance Canada (FIN), Financial Consumer Agency of Canada (FCAC), Financial Transactions and Reports Analysis Centre of Canada (FINTRAC), Global Affairs Canada (GAC), Health Canada (HC), House of Commons, Housing, Infrastructure and Communities Canada (HICC), Immigration, Refugees and Citizenship Canada (IRCC), Indigenous Services Canada (ISC), Innovation, Science and Economic Development Canada (ISED), Justice Canada (JC), Natural Resources Canada (NRCan), Office of the Privacy Commissioner of Canada (OPC), Office of the Superintendent of Financial Institutions Canada (OSFI), Patented Medicine Prices Review Board (PMPRB), Prime Minister's Office (PMO), Privy Council Office (PCO), Public Health Agency of Canada (PHAC), Public Service Commission of Canada (PSC), Senate of Canada, Transport Canada (TC)
What they're lobbying on (36)Hide details
- Advocacy on digital economy and cyber security issues such as artificial intelligence, digital safety and lawful access. Target audiences include Finance, ISED, Health and OSFI.
- Protecting Privacy and Consumer Data Act: seeking workable approaches to privacy rules affecting life and health insurers. Target audiences include ISED / AI and Digital Innovation.
- Discussions related to protecting against fraud and financial crimes
- Advocate for changes to facilitate adoption of auto features for retirement savings.
- Advocate for legislative or regulatory changes to allow for automatic features in workplace pension plans.
- Discussions related to the implementation of CRA Notice 344
- Consultation on the National Strategy on mental health of men and boys
- Discussions related to Bill S-5 Connected Care for Canadians Act.
- FCAC direction to update complaint-handling information for insurers
- Discussions related to drug pricing, including decisions, policies and processes of the Patented Medicine Prices Review Board (PMPRB)
- Discussions related to supply and shortages of drugs in Canada, including the Multi-Stakeholder Steering Committee.
- Discussions related to regulatory burden, including “cutting red tape”.
- Impacts on Canadian insurers of proposed U.S. tax measures.
- Discussions relating to the efficiency and effectiveness of the financial sector regulatory system as it pertains to insurance companies.
- Discussing plans on the Data Collection Modernization initiative
- Promotion of a broader range of investments by insurance companies (e.g., farmland, timberland, fintechs)
- Statutory review of the Insurance Companies Act as it relates to insurance products and investments.
- Discussions related to the implementation of national pharmacare including bilateral agreements with provinces and territories; the committee of experts on the implementation of pharmacare and the advisory panel on bulk purchasing.
- Promotion of pension products, including decumulation solutions.
- Discussions related to the implementation of the Interpretation letter on the Canada health act related to physician equivalent services.
- Inter-provincial harmonization and trade barriers as it relates to insurance products.
- Discussions related to the financial sector policy review.
- Office of the Superintendent of Financial Institutions (OSFI). Guidelines related to risk management, capital and accounting for insurance companies. This includes capital charges for infrastructure investments under the LICAT.
- International Trade with respect to opening trade relations, regulations, foreign ownership and national treatment in foreign markets, with regards to India, Europe, China, Japan, Trans-Pacific partnership (TPP), Canada-United States-Mexico Agreement (CUSMA), Plurilateral Trade In Services Agreement (TISA) and the World Trade Organization (WTO).
- Work to ensure that the income tax act does not put insurance companies at a competitive disadvantage.
- Promotion of risk-based and principles-based regulation for financial institutions regulations.
- Personal Information Protection and Electronic Documents Act: seeking workable approaches to privacy rules affecting life and health insurers when the Act is updated.
- Income Tax Regulations (section 6(1)(f) as it relates to income tax withholding on wage loss replacement plans (disability income benefits).
- Income Tax Regulations, Part XIV.
- Income Tax Regulations, Part III: Updating income tax rules for life insurance policies.
- Income Tax Act, Section 146: Retirement income recommendations regarding the treatment of life insurance companies; Section 146.2 (TFSAs); Section 146.3 (RRIFs).
- Income Tax Act, Part VI as it relates to capital tax on financial institutions.
- Financing infrastructure projects, as it relates to investments by insurers
- Financial Transactions and Reports Analysis Centre of Canada (FINTRAC) risk-based guidance as it relates to life insurance
- Employment Insurance (EI) reform as it relates to disability benefits; and EI Premium Reduction Program issues.
- Amendments to Proceeds of Crime (Money Laundering) and Terrorist Financing rules as they affect insurance companies
Registration 932504-15575-105. Look it up in the official Registry
Reported meetings
Spreadsheet-
Reported by Stephen Frank · In-house (organization)
- Yash Nanda · Senior Policy Advisor, Prime Minister's Office (PMO)
Discussions related to the implementation of national pharmacare including bilateral agreements with provinces and territories; the committee of experts on the implementation of pharmacare and the advisory panel on bulk purchasing. Read more
Discussions related to regulatory burden, including “cutting red tape”.
Inter-provincial harmonization and trade barriers as it relates to insurance products.
Discussions related to the implementation of the Interpretation letter on the Canada health act related to physician equivalent services.
-
Reported by Stephen Frank · In-house (organization)
- Chi Nguyen · Member of Parliament
Discussions related to the implementation of national pharmacare including bilateral agreements with provinces and territories; the committee of experts on the implementation of pharmacare and the advisory panel on bulk purchasing. Read more
Discussions related to the implementation of the Interpretation letter on the Canada health act related to physician equivalent services.
-
Reported by Stephen Frank · In-house (organization)
- Ted Falk · Member of Parliament
Discussions related to regulatory burden, including “cutting red tape”. Read more
Discussions related to the implementation of the Interpretation letter on the Canada health act related to physician equivalent services.
Financing infrastructure projects, as it relates to investments by insurers
-
Reported by Stephen Frank · In-house (organization)
- Tony Loffreda · Senator, Senate of Canada
Inter-provincial harmonization and trade barriers as it relates to insurance products. Read more
Financing infrastructure projects, as it relates to investments by insurers
Discussions related to regulatory burden, including “cutting red tape”.
-
Reported by Stephen Frank · In-house (organization)
- Claude Carignan · Senator, Senate of Canada
Discussions related to the implementation of national pharmacare including bilateral agreements with provinces and territories; the committee of experts on the implementation of pharmacare and the advisory panel on bulk purchasing. Read more
Discussions related to regulatory burden, including “cutting red tape”.
Financing infrastructure projects, as it relates to investments by insurers
-
Reported by Stephen Frank · In-house (organization)
- Greg Orencsak · Deputy Minister, Health Canada (HC)
Discussions related to the implementation of national pharmacare including bilateral agreements with provinces and territories; the committee of experts on the implementation of pharmacare and the advisory panel on bulk purchasing. Read more
Discussions related to the implementation of the Interpretation letter on the Canada health act related to physician equivalent services.
-
Reported by Stephen Frank · In-house (organization)
- Maggie Chi · Parliamentary Secretary to Minister of Health, Health Canada (HC)
Discussions related to the implementation of the Interpretation letter on the Canada health act related to physician equivalent services. Read more
Discussions related to the implementation of national pharmacare including bilateral agreements with provinces and territories; the committee of experts on the implementation of pharmacare and the advisory panel on bulk purchasing.
-
Reported by Stephen Frank · In-house (organization)
- Greg Reade · Associate Assistant Deputy Minister, Finance Canada (FIN)
Inter-provincial harmonization and trade barriers as it relates to insurance products. Read more
Financing infrastructure projects, as it relates to investments by insurers
Discussions related to regulatory burden, including “cutting red tape”.
-
Reported by Stephen Frank · In-house (organization)
- Martine Hébert · Senator, Senate of Canada
Discussions related to the implementation of national pharmacare including bilateral agreements with provinces and territories; the committee of experts on the implementation of pharmacare and the advisory panel on bulk purchasing. Read more
Discussions related to regulatory burden, including “cutting red tape”.
Financing infrastructure projects, as it relates to investments by insurers
-
Reported by Stephen Frank · In-house (organization)
- Adam Chambers · Member of Parliament
Financing infrastructure projects, as it relates to investments by insurers Read more
Discussions related to the implementation of national pharmacare including bilateral agreements with provinces and territories; the committee of experts on the implementation of pharmacare and the advisory panel on bulk purchasing.
Discussions related to regulatory burden, including “cutting red tape”.
-
Reported by Stephen Frank · In-house (organization)
- Clément Gignac · Senator, Senate of Canada
Discussions related to regulatory burden, including “cutting red tape”. Read more
Financing infrastructure projects, as it relates to investments by insurers
Discussions related to the implementation of national pharmacare including bilateral agreements with provinces and territories; the committee of experts on the implementation of pharmacare and the advisory panel on bulk purchasing.
-
Reported by Stephen Frank · In-house (organization)
- Wayne Long · Secretary of State (Canada Revenue Agency and Financial Institutions) (Secretary of State), Finance Canada (FIN)
- Kevin Collins · Chief of Staff, Finance Canada (FIN)
Discussions related to the implementation of national pharmacare including bilateral agreements with provinces and territories; the committee of experts on the implementation of pharmacare and the advisory panel on bulk purchasing. Read more
Financing infrastructure projects, as it relates to investments by insurers
Discussions related to regulatory burden, including “cutting red tape”.
-
Reported by Stephen Frank · In-house (organization)
- Bayan Kadri · Policy Advisor, Office of the Minister of Housing, Infrastructure and Communities, Housing, Infrastructure and Communities Canada (HICC)
Financing infrastructure projects, as it relates to investments by insurers
-
Reported by Stephen Frank · In-house (organization)
- Frank Lofranco · Deputy Commissioner, Financial Consumer Agency of Canada (FCAC)
FCAC direction to update complaint-handling information for insurers
-
Reported by Stephen Frank · In-house (organization)
- Kevin Collins · Chief of Staff, Finance Canada (FIN)
- Joshua Mbandi · Director of Policy, Finance Canada (FIN)
Discussions related to the implementation of national pharmacare including bilateral agreements with provinces and territories; the committee of experts on the implementation of pharmacare and the advisory panel on bulk purchasing. Read more
Discussions related to regulatory burden, including “cutting red tape”.
Promotion of a broader range of investments by insurance companies (e.g., farmland, timberland, fintechs)
Financing infrastructure projects, as it relates to investments by insurers
-
Reported by Stephen Frank · In-house (organization)
- Adam Chambers · Member of Parliament
Discussions related to the implementation of national pharmacare including bilateral agreements with provinces and territories; the committee of experts on the implementation of pharmacare and the advisory panel on bulk purchasing. Read more
Financing infrastructure projects, as it relates to investments by insurers
-
Reported by Stephen Frank · In-house (organization)
- Greg Reade · Associate Assistant Deputy Minister, Finance Canada (FIN)
Promotion of a broader range of investments by insurance companies (e.g., farmland, timberland, fintechs) Read more
Discussions related to regulatory burden, including “cutting red tape”.
-
Reported by Stephen Frank · In-house (organization)
- Sandenga Yeba · Director of Policy & Deputy Chief of Staff, Health Canada (HC)
Discussions related to the implementation of national pharmacare including bilateral agreements with provinces and territories; the committee of experts on the implementation of pharmacare and the advisory panel on bulk purchasing. Read more
-
Reported by Stephen Frank · In-house (organization)
- Yash Nanda · Senior Policy Advisor, Prime Minister's Office (PMO)
Discussions related to drug pricing, including decisions, policies and processes of the Patented Medicine Prices Review Board (PMPRB) Read more
Discussions related to the implementation of national pharmacare including bilateral agreements with provinces and territories; the committee of experts on the implementation of pharmacare and the advisory panel on bulk purchasing.
-
Reported by Stephen Frank · In-house (organization)
- Sandenga Yeba · Director of Policy & Deputy Chief of Staff, Health Canada (HC)
Discussions related to the implementation of national pharmacare including bilateral agreements with provinces and territories; the committee of experts on the implementation of pharmacare and the advisory panel on bulk purchasing. Read more
Discussions related to drug pricing, including decisions, policies and processes of the Patented Medicine Prices Review Board (PMPRB)
Discussions related to the implementation of the Interpretation letter on the Canada health act related to physician equivalent services.
-
Reported by Stephen Frank · In-house (organization)
- Sandenga Yeba · Director of Policy & Deputy Chief of Staff, Health Canada (HC)
Discussions related to drug pricing, including decisions, policies and processes of the Patented Medicine Prices Review Board (PMPRB) Read more
Discussions related to regulatory burden, including “cutting red tape”.
Discussions related to the implementation of national pharmacare including bilateral agreements with provinces and territories; the committee of experts on the implementation of pharmacare and the advisory panel on bulk purchasing.
Discussions related to the implementation of the Interpretation letter on the Canada health act related to physician equivalent services.
-
Reported by Stephen Frank · In-house (organization)
- Greg Orencsak · Deputy Minister, Health Canada (HC)
Discussions related to the implementation of national pharmacare including bilateral agreements with provinces and territories; the committee of experts on the implementation of pharmacare and the advisory panel on bulk purchasing. Read more
Discussions related to drug pricing, including decisions, policies and processes of the Patented Medicine Prices Review Board (PMPRB)
Discussions related to the implementation of the Interpretation letter on the Canada health act related to physician equivalent services.
-
Reported by Stephen Frank · In-house (organization)
- Greg Reade · Associate Assistant Deputy Minister, Finance Canada (FIN)
Financing infrastructure projects, as it relates to investments by insurers
-
Reported by Stephen Frank · In-house (organization)
- Matthew O'Connell · Deputy Director of Policy, Finance Canada (FIN)
Financing infrastructure projects, as it relates to investments by insurers Read more
Impacts on Canadian insurers of proposed U.S. tax measures.
-
Reported by Stephen Frank · In-house (organization)
- Chris Forbes · Deputy Minister, Finance Canada (FIN)
- Greg Reade · Associate Assistant Deputy Minister, Finance Canada (FIN)
Impacts on Canadian insurers of proposed U.S. tax measures. Read more
Inter-provincial harmonization and trade barriers as it relates to insurance products.
Financing infrastructure projects, as it relates to investments by insurers
From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.